Rapid initiation and agile delivery of a complex Phase I COVID vaccine study
This successful trial was completed when the milestone of database lock was achieved just four weeks after last patient last visit.
Clinical Research
uk Biotech
Global real-world evidence (RWE) pilot study in antimicrobial resistance (AMR)
8,060 hospitalised patient records were submitted — 7,444 (92%) were complete enough to include in the final analysis.
Real World Evidence
top 10 Pharma
Open-access portal for a global antimicrobial resistance (AMR) surveillance programme
8+ million records across 900,000+ clinical isolates — searchable by pathogen, antimicrobial, demographics, phenotype and genotype.
AMR Surveillance
top 10 Pharma
Accelerating patient recruitment in a specialised anti-infective therapy area
Within the first month of Micron starting the study, monthly patient recruitment attained the target.
Clinical Research
pharma
Phase IIb/c trial of a novel anti-tuberculosis oral regimen completed within one year
Recruitment of patients with tuberculosis can be challenging, and retaining participation of the full quota of 122 patients to assess response to treatment was crucial to the trial’s success.
Clinical Research
pharma
Let's build a partnership!
Get in touchOur Offices
Micron Research
109B Lancaster Way Business Park
CB6 3NX, Ely, Cambridgeshire
England, United Kingdom
US Micron
12022 Blue Valley Parkway, Overland Park
Kansas 66213, United States of America
Clindev
Route 21 Corporate Park, 5 Regency Drive, Building C
Irene 0157, Centurion, South Africa
EU Micron
Harju maakond, Tallinn, Kesklinna linnaosa
Viru väljak 2, Tallinn 10111, Estonia
LogicTrials
Route 21 Corporate Park, 9 Regency Drive, Building B
Irene 0157, Centurion, South Africa
Services
-
Integrated Clinical Development Services
-
Drug Distribution and Logistics
-
Software
© The Micron Group 2025